In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Iron deficiency in patients with heart failure: time for action
Session

Event : Heart Failure 2017

Topic : Chronic Heart Failure: Comorbidities

  • Session type : Satellite Symposium
  • Date : 30 April 2017
  • Time : 12:45 - 14:00
  • Sponsored by Vifor Pharma

5 presentations in this session

Welcome and introduction.

Event : Heart Failure 2017

  • Session : Iron deficiency in patients with heart failure: time for action
  • Speaker : A Cohen-Solal (Paris,FR)
  • Sponsored by Vifor Pharma

Burden and impact of iron deficiency in heart failure.

Event : Heart Failure 2017

  • Session : Iron deficiency in patients with heart failure: time for action
  • Speaker : CS Lam (Singapore,SG)
  • Sponsored by Vifor Pharma

Current evidence for the treatment of iron deficiency in heart failure.

Event : Heart Failure 2017

  • Session : Iron deficiency in patients with heart failure: time for action
  • Speaker : D van Veldhuisen (Groningen,NL)
  • Sponsored by Vifor Pharma

Future directions for the treatment of iron deficiency in heart failure.

Event : Heart Failure 2017

  • Session : Iron deficiency in patients with heart failure: time for action
  • Speaker : P Ponikowski (Wroclaw,PL)
  • Sponsored by Vifor Pharma

Panel discussion.

Event : Heart Failure 2017

  • Session : Iron deficiency in patients with heart failure: time for action
  • Speaker : A Cohen-Solal (Paris,FR)
  • Sponsored by Vifor Pharma

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are